SCHEMBL17482292

SCHEMBL17482292

CNC(=O)c1ccc2c(c1)CCN(C(=O)Cc1ccccc1)C2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 1/20 0.54
MEN1 O00255 1/20 0.54
TMPRSS2 O15393 2/20 0.50
HDAC6 Q9UBN7 4/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC1 Q13547 2/20 0.47
ALDH1A1 P00352 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ABCB1 P08183 1/20 0.47
ABCC1 P33527 1/20 0.47
HDAC3 O15379 1/20 0.47
KDM4E B2RXH2 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
AKR1C3 P42330 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1264115 0.89 HDAC6 (0.60) KMT2ANPC1RAB9AMEN1TMPRSS2
SCHEMBL1264149 0.83 HDAC6 (0.68) KMT2ANPC1RAB9AMEN1HDAC6
SCHEMBL25605335 0.80 NPC1 (0.78) KMT2ANPC1RAB9AMEN1HDAC8
SCHEMBL29569463 0.80 NPC1 (0.78) KMT2ANPC1RAB9AMEN1HDAC8
SCHEMBL1264537 0.77 HDAC6 (0.57) KMT2ANPC1RAB9AMEN1HDAC6
SCHEMBL1264391 0.77 KMT2A (0.54) KMT2ANPC1MEN1HDAC6HDAC8
SCHEMBL12896016 0.77 TAS2R8 (0.48) TMPRSS2HDAC6HDAC8HDAC1ALDH1A1
SCHEMBL1083136 0.77 HDAC6 (0.53) KMT2ANPC1RAB9AHDAC6HDAC8
SCHEMBL20536415 0.77 L3MBTL1 (0.53) KMT2ANPC1MEN1ALDH1A1L3MBTL1
SCHEMBL4425805 0.76 KDM4E (0.60) KMT2ANPC1RAB9AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160031820-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031820-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC5, HDAC1 KMT2A 37/4885NPC1 1972/4885RAB9A 2715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.